|
|
||||||||
Radiology, Vol 180, 337-339, Copyright © 1991 by Radiological Society of North America
ARTICLES |
HB Gehl, D Vorwerk, KC Klose and RW Gunther
Department of Diagnostic Radiology, Technical University Aachen, Germany.
Enhancement of the pancreas was demonstrated after low-dose (10 mumol/kg) infusion of a new contrast agent for magnetic resonance (MR) imaging, manganese dipyridoxal-diphosphate (Mn-DPDP). To the authors' knowledge, this has not been described previously. The enhancement reached a maximum of 98% +/- 13% (standard deviation) during a long period (greater than 6 hours). Mn-DPDP seems to have potential as a selective contrast agent in MR imaging of the pancreas.
This article has been cited by other articles:
![]() |
W. Schima, R. Fugger, E. Schober, C. Oettl, P. Wamser, F. Grabenwoger, J. M. Ryan, and G. Novacek Diagnosis and Staging of Pancreatic Cancer: Comparison of Mangafodipir Trisodium--Enhanced MR Imaging and Contrast-Enhanced Helical Hydro-CT Am. J. Roentgenol., September 1, 2002; 179(3): 717 - 724. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |